Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The Board of BE Group resolves on terms for the rights issue

Not for distribution, directly or indirectly, in or to the Unites States, Australia, Hong Kong, Canada or Singapore or any other jurisdiction where such distribution of this press release would be subject to legal restrictions. Summary · Shareholders in BE Group will have preferential right to subscribe for 5 new shares for every existing 2 shares, i.e. subscription ratio 5:2 · The subscription price is SEK 1.40 per share which represents a total rights issue proceeds of MSEK 259.7 before costs related to the transaction · The subscription period will run from and including 21

Report from Annual General Meeting of Vitrolife AB (publ)

At Vitrolife’s Annual General Meeting yesterday, May 5, the following, amongst other things, was decided: · The Board’s proposed dividend of SEK 1.50 per share for the financial year 2014 was approved. Thursday May 7, 2015 was adopted as the record day. · Re-election of Board members Fredrik Mattsson, Tord Lendau, Barbro Fridén, Carsten Browall and Pia Marions and new election of Jón Sigurdsson, in accordance with the election committee’s proposal. Carsten Browall was re-elected Chairman of the Board. · Remuneration to the members of the Board shall be totalling SEK 1,440,000,

Medivir’s board of directors has resolved to repurchase own shares

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announce that Medivir’s board of directors has resolved to use the authorisation given by the annual general meeting regarding repurchases of Medivir class B shares. The repurchases will be carried out in batches over time, not longer than up to the next annual general meeting. The execution of the repurchases will depend on market conditions and the repurchases are to be made in accordance with applicable rules. Among other things, the number of shares repurchased on any given day, with the exception for any block

Photocure ASA: Results for first quarter 2015

Oslo, Norway, 6 May 2015: Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused on photodynamic technologies, announces its results for first quarter 2015. Highlights include: (Numbers in brackets are for the corresponding period in 2014) · Total sales revenues of Hexvix®/Cysview® increased 38% in the quarter to NOK 26.7 million · Commercial franchise yielding operating profit of NOK 4.2 million in the quarter, up NOK 4.2 million from last year, driven by increased revenues from Hexvix/Cysview · Significant improvement in financial performance  -

European Parliament urges the Commission to immediately ask the European Food Safety Authority (EFSA) to re-evaluate the use of acetaldehyde

Biohit Oyj Press Release May 6, 2015 at 9:30 a.m. local time (EEST) The motion of the European Parliament´s committee on Environment, Public Health and Food Safety (ENVI) has been accepted containing the key elements regarding acetaldehyde. In the European Parliament Motion for a resolution on Alcohol Strategy (2015/2543(RSP)), it is concluded that food is to be deemed unsafe if it is considered to be injurious to health (Regulation (EC) No 178/2002 of 28 January 2002). European Parliament urges the Commission to immediately ask the European Food Safety Authority (EFSA) to re-

Reminder: Invitation to presentation of Orkla's first quarter 2015 results, Thursday 7 May

Orkla will report first quarter 2015 results on Thursday, 7 May 2015 at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com. A presentation of the quarter results will be held at 8.00 a.m. at Vika Atrium Conference Center, Munkedamsveien 45, Oslo. The presentation will be held in English and may be seen live via webcast at www.orkla.com. You may also follow the presentation live by telephone. Dial-in details: +47 21 03 33 94. Pincode: 6491460. Orkla ASAOslo, 6 May 2015 Ref.: Orkla ASA Senior IR & Communications

Enea aims for Carrier-grade Open Source Networking Operating System (COSNOS) – the software foundation for next generation networking hardware

STOCKHOLM, Sweden, May 6, 2015. Yesterday, Enea (NASDAQ OMX Nordic: ENEA) and ARM announced multiple ARM-based reference implementations of the Open Platform for Network Function Virtualization (OPNFV) software (read more about it here ). Enea’s strategic direction is towards the Carrier-Grade Open Source Network Operating System (COSNOS), and to be a leading provider of software platforms for next generation network nodes and functions. The OPNFV architecture is a given component in those platforms, and Enea

Interim financial report, first quarter 2015

Summary: In the first quarter of 2015, Vestas generated revenue of EUR 1,519m – an increase of 18 percent compared to the year-earlier period. EBIT before special items increased by EUR 39m to EUR 79m. The EBIT margin before special items was 5.2 percent and the free cash flow increased by EUR 170m to EUR 146m compared to the first quarter of 2014. The intake of firm and unconditional wind turbine orders amounted to 1,750 MW in the first quarter of 2015. The value of the wind turbine backlog amounted to EUR 7.5bn at 31 March 2015. In addition to the wind turbine order backlog, Vestas had

“Vita” – a photographic performance by Iris Brosch in the form of a vibrant invitation to visit Saxony-Anhalt from the Biennale in Venice

Saxony-Anhalt celebrates Cranach the Younger with a world premiere. Magdeburg/Venice. With the state exhibition “Cranach the Younger 2015”, from 26th June until 1st November 2015, the homeland of the reformation is to celebrate the 500th birthday of Lucas Cranach the Younger. It is the first ever exhibition in the world to be dedicated to the life and work of the master. At original venues in Lutherstadt Wittenberg, Dessau and Wörlitz, the exhibition organisers will be presenting the most important and valuable works of art from the German renaissance in the form of a superb

Solid performance in the first quarter of the year. Full year guidance maintained

HIGHLIGHTS· Kåre Schultz appointed as new president and CEO. He will join Lundbeck on 20 May 2015 (see separate release) · Core revenue remained stable compared to last year as the expected genericization of both Cipralex and Ebixa sales are off-set by appreciation of key currencies and growth in other products. Core EBIT margin reached 6% in spite of significant launch costs · The launch program of the strategic core products Abilify Maintena®, Brintellix®, Northera® and Selincro® continued in the first quarter of 2015 with more than 20 individual country launches · Revenue from

Etrion Releases First Quarter 2015 Results

Etrion Releases First Quarter 2015 Results May 6, 2015, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today released its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three months ended March 31, 2015. Operational Highlights · Production Italy: Produced 16.9 million (2014: 16.5 million) kilowatt-hours (“kWh”) of solar electricity during the three months ended March 31, 2015, from the Company’s 100%-owned 60 MW portfolio

Press release from Genovis AB (publ) Annual General Meeting May 5, 2015

The Annual General Meeting adopted the following resolutions: · The balance sheet and income statement were adopted after the Meeting resolved to reduce the statutory reserve by SEK 6,178,264 to cover the loss so that SEK 0 is carried forward. · The Board and the Chief Executive Officer were discharged from liability. · The Board shall consist until the next AGM of five ordinary members without deputies. · Ordinary members Kenth Petersson, Jacob Engellau, Mikael Lönn and Lena Mårtensson Wernrud were re-elected. Sarah Fredriksson was elected to serve as a new Board member.

Invitation to a teleconference/audiocast and presentation of Aerocrine’s Q1 Report 2015

Solna, Sweden – May 6, 2015 - Aerocrine AB (Nasdaq Stockholm: AERO) hereby invites to a teleconference/audiocast and presenting of Aerocrine’s first quarter result 2015 on May 12, 2015 at 09:30 CET. Aerocrine will publish its report for the first quarter 2015 on May 12, 2015. A teleconference/audiocast will be held for analysts, the media and investors on the same day at 09:30 CET. Scott Myers, CEO and Marshall Woodworth, CFO will present the report. The presentation will be held in English and it is possible to participate by teleconference or audiocast. The audiocast can be

Hansa Medical AB establishes a US medical advisory board for IdeS in kidney transplantation

Hansa Medical AB today announced the inception of a US medical advisory board for IdeS in kidney transplantation. The board will assist the company in developing IdeS within transplantation in sensitized patients.Hansa Medical AB has previously initiated a similar European advisory board with leading transplantation experts in Europe. The US medical advisory board will be valuable to the further development of IdeS. The two boards are connected through the joint board member, Professor Kathryn Wood, Oxford, UK. Dr Stanley JordanDr Stanley Jordan, MD, the chairman of the US advisory

Evolution Gaming: Interim Report January-March 2015

First quarter of 2015 (Q1 2014) · Revenues increased by 43% to EUR 15.4 million (10.8) · Profit for the period amounted to EUR 1.4 million (2.1) · Earnings per share amounted to EUR 0.04 (0.06) · Non-recurring expenses for the IPO amounted to EUR 4.0 million · Excluding non-recurring expenses, EBITDA amounted to EUR 6.2 million (3.2), corresponding to a margin of 40% (29) Events during the first quarter of 2015 · PokerStars went live with an extensive and dedicated environment · Evolution granted a Combined Remote Operating Licence from the UK Gambling Commission

Interim report January – March 2015

January – March (compared with the first quarter 2014) •      Gross cash collections increased by 48 per cent to SEK 791m (SEK 536m). •      Total revenue increased by 40 per cent to SEK 499m (SEK 358m). •      EBIT totalled SEK 161m (SEK 121m) adjusted for costs in connection to the listing. EBIT totalled SEK 115m. •      EBIT margin was 32 per cent (34 per cent), adjusted for costs in connection to the listing. •      Profit before tax amounted to SEK 52m (SEK 50m), adjusted for costs in connection to the listing. •      Portfolio acquisitions totalled SEK 273m (SEK 434m)

24 percent sustainability labelled fashion at KappAhl this spring

At KappAhl, the efforts have intensified to ensure more sustainable fashion finds its way to the customer's wardrobe. This spring, 24 percent of the fashion chain's assortment is sustainability labelled. The collaboration with the famous photographer is this spring's highlight.      "KappAhl and Mary found one another at once through their great commitment to sustainability", Carina Ladow, Vice President Assortment and Design at KappAhl, says. The result of the collaboration, the "Dreams through a Lens" collection, combines sustainably produced materials and classic fashion that endures.

Bactiguard enters distribution agreement for Israel

Bactiguard has entered an exclusive distribution agreement for Israel with Dover Medical & Scientific Equipment Ltd. The agreement covers sales of all products in the Bactiguard Infection Protection portfolio.“Changing our market strategy for Israel from direct sales to sales via a distributor is a more cost efficient way of expanding our presence and sales in this market. The number of patients that die from infections caused by resistant bacteria in Israeli hospitals is estimated to more than 4 000 per year, so there is a great need for preventive solutions”, says Niels Christiansen, CEO.

Communiqué from the AGM of Mycronic AB (publ)

Täby, 6 May, 2015 – The Annual General Meeting (AGM) of Mycronic AB (publ) on 5 May, 2015 dealt with the following items among others: Election of Board membersThe AGM decided that the Board of Directors for the period running until the end of the next AGM shall be composed of six members with no deputy members. The AGM re-elected Board membersKatarina Bonde, Ulla-Britt Fräjdin-Hellqvist, Anders Jonsson, Magnus Lindquist, Eva Lindqvist and Patrik Tigerschiöld. Patrik Tigerschiöld was elected Chairman of the Board.Remuneration to the Board of DirectorsThe AGM decided that the

Interim Report, January-March 2015

January-March 2015[1] · Net sales reached SEK 4,583 million (3,365), corresponding to an increase of 36%, 24% at constant exchange rates compared to the previous year. · EBITDA, excluding non-recurring items, was SEK 1,403 million (1,010), corresponding to an increase of 39%, 26% at constant exchange rates and yielding a 30.6% margin (30.0). · Non-recurring effects had a SEK 218 million negative impact on earnings before tax. · Profit after tax amounted to SEK 226 million (260). · Earnings per share reached SEK 0.62 (0.83)[2]. Excluding non-recurring effects, earnings per

Interim Report SciBase Jan 1 - Mar 31 2015

The quarter in figures · Total net sales amounted to TSEK 1,057 (64). · The loss after tax amounted to TSEK 9,179 (9,012). · The loss per share amounted to SEK 0.05 (0.05). · The cash flow from current operations was negative in the amount of TSEK 9,197(10,250). Important events during the quarter · The wholly owned subsidiary SciBase GmbH was formed with the aim of strengthening the Group’s sales and marketing focus in Germany. · Tobias Bergenblad was appointed as the new Global Sales Manager. · Patents granted in Australia and Japan. Important events after

Repayment of Unsecured Bonds

5 May 2015 Ophir Energy plc Repayment of Unsecured Bonds Ophir Energy plc ("Ophir") advises that certain bondholders have exercised their put option totalling approximately $45 million of the $150 million Unsecured Bonds that were previously issued by its subsidiary Salamander Energy plc ("Salamander"). The put option, at an option price of 101%, was triggered by the acquisition of Salamander by Ophir; the put option expired on 1 May 2015. Ophir will be completing a review of its debt structure during the second half of 2015 with a view to optimising its balance sheet. Ends

There are no items matching the current filter
There are no more items matching the current filter
Back to top